Home
ASCO 2023 Expert Report in HR positive, HER2 negative breast cancer by Catherine Harper-Wynne
European Society for Medical Oncology (ESMO)
19 มิ.ย. 2023
การดู 6,406 ครั้ง
ASCO 2023 Expert Report on novelties in the treatment of colorectal cancer by S. Stintzing
Ask the expert: Early-stage hormone receptor-positive, HER2-positive & triple-positive breast cancer
What's the Best Diet for Hormone Receptor-Positive Breast Cancer? The Ultimate Guide
Sharing my Her2+ Breast Cancer Diagnosis Story at 35 years old
[PODCAST] Food Choice | EP.13 - อาหารชะลอวัย Anti-Aging Food
Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast Cancer
DCIS - A Pathologist's Perspective | 2023 Ductal Carcinoma In Situ Patient Forum
Adjuvant Therapy | 2023 Best of Breast Conference
Virtual Pink House: Understanding HER2 Breast Cancer Recurrence
[PODCAST] Pet Talk | EP.7 - 7 พฤติกรรมต้องห้าม ไม่ควรทำกับสุนัขเด็ดขาด!
2023 What Changes Monday Morning? | ESMO Breast Cancer Webinar
Advanced Stage Hormone Positive Breast Cancer Fine Tuning Sequential Endocrine and Targeted Therapy
A New View of the Spectrum of HER2 Expression and Significance of HER2 Low in Breast Cancer
Hormone Receptor-Positive and HER2-Positive Breast Cancer: A Medical Update
Updates in HER2 Testing in Breast Cancer
Exploring today’s attitudes for tomorrow’s election
Virtual Pink House: Reducing Recurrence Risk of HER2 Positive Breast Cancer
ClarifyingComplexities of ExpandingTreatmentOptionsFor AdvancedAndEarly-Stage HR+/HER2- BreastCancer
New Frontiers in Triple Negative Breast Cancer
Ask the expert: Hormone receptor-positive breast cancer